• 
  Adam Marcus, Emory University: SaGA for Cancer Drug Discovery
• 
  Scott Boden, Sree Sangadala, Nick Willett: 12X Bone Regeneration for Spinal Fusion
• 
  Yuan Li, Georgia State University: Co-PI for SIRPant Cellular Immunotherapy for Solid Tumors
• 
  Ned Waller, Emory University: Co-PI for SIRPant Cellular Immunotherapy for Solid Tumors
• 
  Peter Yunker, Georgia Tech: Co-PI for Heteroresistance AST

Five promising biomedical research innovations across three campuses have been chosen for Biolocity’s newest cohort.

Faculty at Georgia Tech, Emory University, and Georgia State University have been selected to receive a broad range of support from Biolocity to accelerate the commercialization of their patient impacting technologies. During their funding period, each team will receive project management and work directly with business experts and consultants to de-risk their technology and advance its development.